https://hotcopper.com.au/posts/50904453/singlerecovery rates are different yet Hotcopper accepts unsubstantiated table by anonymous poster
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%